An Elevated Arterial Enhancement Fraction Is Associated With Clinical and Imaging Indices of Liver Fibrosis and Cirrhosis
Authors:
- Susanne BonekampSBSusanne Bonekamp
- Bernhard GeigerBGBernhard Geiger
- Ihab R. KamelIKIhab R. Kamel
- 1 January 2012
- journal article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 36 (6) , 681-689
Abstract
The objective of this study was to determine whether arterial enhancement fraction (AEF) is associated with the degree of liver fibrosis and cirrhosis in patients with chronic liver disease. Sixty-five patients (mean age, 55.8 years; 19 female patients) underwent triple-phase computed tomography scanning. Mean AEF was determined for the left and right hepatic lobe of the liver using a prototypical software module and compared between groups of different liver fibrosis grade. Mean AEF was higher in patients with liver disease compared with those without liver disease. Mean AEF differed significantly between patients with normal liver or mild fibrosis (category 1), moderate to severe fibrosis (category 2), and cirrhosis (category 3). Receiver operating characteristic curve analysis determined an area under the curve of 0.79/0.78, with an optimal cutoff for mean AEF of 9.2/16.8, for differentiating between category 2 or higher/category 3 disease. The mean hepatic AEF can provide an accurate, fast, noninvasive assessment of the degree of fibrosis in chronic liver disease.Keywords
This publication has 37 references indexed in Scilit:
- Quantitative Color Mapping of the Arterial Enhancement Fraction in Patients With Diffuse Liver DiseaseAmerican Journal of Roentgenology, 2011
- Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosisBritish Journal of Radiology, 2011
- Assessment of Chronic Hepatitis and Fibrosis: Comparison of MR Elastography and Diffusion-Weighted ImagingAmerican Journal of Roentgenology, 2011
- Repeatability of magnetic resonance elastography for quantification of hepatic stiffnessJournal of Magnetic Resonance Imaging, 2010
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Exceeding the limits of liver histology markersJournal of Hepatology, 2009
- Liver cirrhosisThe Lancet, 2008
- Nicht invasive Beurteilung des Leberfibrosestadiums mit der transienten Elastografie (FibroScan): Aktueller Stand und PerspektivenZeitschrift für Gastroenterologie, 2007
- Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver diseaseGut, 2006
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973